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Abstract The small GTPases Rab4, Rab5 and Rab7 are
endosomal proteins which play important roles in the regulation
of various stages of endosomal trafficking. Rab4 and Rab5 have
both been localized to early endosomes and have been shown to
control recycling and endosomal fusion, respectively. Rab7, a
marker of the late endosomal compartment, is involved in the
regulation of the late endocytic pathway. Here, we compare the
role of Rab4, Rab5 and Rab7 in early and late endosomal
trafficking in HeLa cells monitoring ligand uptake, recycling and
degradation. Expression of the Rab4 dominant negative mutant
(Rab4AS22N) leads to a significant reduction in both recycling
and degradation while, as expected, Rab7 mutants exclusively
affect epidermal growth factor (EGF) and low density lipoprotein
degradation. As also expected, expression of the dominant
negative Rab5 mutant perturbs internalization kinetics and
affects both recycling and degradation. Expression of Rab4WT
and dominant positive mutant (Rab4AQ67L) changes dramati-
cally the morphology of the transferrin compartment leading to
the formation of membrane tubules. These transferrin positive
tubules display swellings (varicosities) some of which are positive
for early endosomal antigen-1 and contain EGF. We propose
that the Rab4GTPase is important for the function of the early
sorting endosomal compartment, affecting trafficking along both
recycling and degradative pathways. ß 2001 Federation of
European Biochemical Societies. Published by Elsevier Science
B.V. All rights reserved.
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1. Introduction
Eukaryotic receptor-mediated endocytosis is a fundamental
cellular process whereby ligands, bound with a high degree of
speci¢city to cell surface receptors, are internalized as part of
the plasma membrane lipid bilayer [1]. This event is accom-
plished by the formation of clathrin coated pits leading to the
generation of clathrin coated vesicles which ‘pinch o¡’ into
the cell. The internalized clathrin coated vesicle is then un-
coated and the receptor/ligand complexes are transported to
early endosomes (EE) [2] which function as the primary sort-
ing location in this pathway [3,4]. In the early/sorting endo-
some, molecules destined for degradation are sorted towards
the late endosome and molecules destined for recycling are
transported either directly back to the plasma membrane
(fast recycling) or indirectly via the perinuclear ‘recycling
compartment’ (RC) [5^7]. Despite the fact that the molecular
events underlying such transport steps are unclear, the kinetics
of endocytic tra⁄cking of several markers such as transferrin
(Tfn), epidermal growth factor (EGF) and low density lipo-
protein (LDL) have been well documented and a number of
proteins are known to be involved in these transport events
[8,9]. One group of proteins which are necessary for e⁄cient
membrane transport through both the biosynthetic and endo-
cytic route are the Rab GTPases, for reviews see [10^14]. The
Rab proteins form the most extensive branch of the ras
GTPase superfamily [15], are localized to distinct organelles
of the biosynthetic and endocytic pathways, and are impli-
cated in the control of membrane tra⁄cking at speci¢c steps.
For example, Rab4, Rab5, and Rab11 are localized to EE and
serve di¡erent functions. Rab4 has been shown to be involved
in the regulation of recycling from the EE and, in particular,
Tfn receptor (TfR) recycling [16,17]. Rab5 is important in the
homotypic fusion between EE as well as in the transport to
the early endosomal compartment [18^20]. In addition, it
seems to be also necessary for budding of vesicles from the
plasma membrane and has been suggested to regulate trans-
port beyond EE [21]. Rab11, on the other hand, has been
demonstrated to function in transport through the RC
[22,23]. Two Rab proteins are localized to the late endosomal
compartment, Rab7 and Rab9 [24,25]. Rab7 has been shown
to control late endocytic tra⁄cking [26^29] while Rab9 regu-
lates transport from late endosomes to the trans Golgi net-
work [25]. In the early endosomal pathway, Rab4 and Rab5
appear to function sequentially, since increased expression of
Rab5 leads to an increase in £uid phase and receptor-medi-
ated endocytosis and generates enlarged EE, suggesting that
Rab5 regulates the clathrin coated pathway of receptor inter-
nalization and transport into the EE [19,20]. On the other
hand, cells overexpressing Rab4 exhibit normal kinetics of
endocytosis but display a reduced steady state of £uid phase
markers and an accumulation of TfR on the cell surface [17].
Rab4 has therefore been implicated in the regulation of mem-
brane recycling from the EE to the RC or directly to the
plasma membrane [30]. Rab4 has not been found on late
endosomes or co-localizing with Rab7 [31] also arguing for
Rab4 function at a location prior to the late endosomal com-
partment.
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In order to better understand Rab4 function, we monitored
the e¡ects of expression of di¡erent Rab4 mutants on Tfn,
LDL and EGF uptake and recycling. Furthermore, we exam-
ined Rab4 e¡ects on LDL and EGF degradation. We then
compared the Rab4 data with Rab5 and Rab7 function in the
endocytic pathway. Tfn, EGF and LDL are commonly used
physiological endocytic markers which bind to their respective
receptors on the cell surface. Subsequent to binding, the li-
gand^receptor complex is internalized via clathrin coated pits.
In the early sorting endosome the EGF and LDL dissociate
from their respective receptors and the bulk of these ligands is
then delivered to the late/degradative compartments. Tfn, on
the other hand, is the classical recycling marker which is
transported (with its receptor) to the cell surface, either di-
rectly or via the perinuclear RC. The data presented here
demonstrate that the (GDP-locked) dominant negative
Rab4S22N mutant leads to a substantial reduction in both
recycling and degradation.
In addition to the quantitative assays, we qualitatively
monitored the e¡ect of the expression of the Rab4 mutants
on the distribution of the TfR positive compartment by im-
muno£uorescence techniques. In these experiments, we ob-
served morphological abnormalities of the early (Tfn positive)
endosomal compartment upon expression of Rab4. The most
dramatic of which are detected on expression of Rab4WT and
the dominant positive (GTPase de¢cient) Rab4Q67L mutant,
where we visualize the formation of a Tfn positive membrane
tubular structure. On the other hand, Rab4S22N leads to the
formation of a more vesicular perinuclear Tfn positive com-
partment.
Since expression of Rab4GDP reduces recycling and degra-
dation of endocytic markers, we propose a role for the
Rab4GTPase in the organization/function of the early sorting
endosome.
2. Materials and methods
2.1. Plasmids
The myc-tagged Rab5 and Rab7WT and mutant plasmids used in
these studies have been previously described [20,28]. PGEMmyc-
Rab4AWT and pGEMmyc-Rab4AQ67L, were obtained by subclon-
ing the respective Rab4 cDNAs as EcoRI^SalI fragments from pLex-
ARab4AWT and pLexARab4A Q67L [32] into the EcoRI^SalI-di-
gested pGEMmyc. pGEMmyc-Rab4AS22N was constructed by two
stage PCR ampli¢cation of Rab4A, using Rab4A in pUC8 [33] as a
template with the primer Rab4A-ATG+BamHI (5P-ACTAGTGC-
GGATCCTCCGAAACCTACGATTTTTTGT-3P) and the primer
Rab4AS22N (5P-GAAGTAAGCAATTTTTGCCAGTTCC-3P) creat-
ing the mutation. This ¢rst round PCR product was then used as
a primer together with a pUC8 speci¢c downstream primer
(5P-GTGCCAAGCTTGGCTGC-3P) and the full length Rab4AS22N
PCR product was cloned into the BamHI site of pBTM116 (pLex).
The Rab4AS22N cDNA fragment was subcloned from this source
into pGEMmyc as an EcoRI^SalI fragment.
2.2. Cell culture and transient transfection
Tissue culture reagents were from Gibco BRL and Biowhittaker.
HeLa cells were grown in DMEM supplemented with 10% FCS, 2 mM
glutamine, 100 U/ml penicillin and streptomycin and grown in a 5%
CO2 incubator at 37‡C. HeLa cells were infected with either the MVA
T7 vaccinia virus [34] or the vT7 recombinant vaccinia virus and
transfected as described [19,35]. The transfection reagent was either
DOSPER or DOTAP obtained from Boehringer Mannheim. Cells
were transfected for 9^10 h and then processed for immuno£uores-
cence, £uorescent marker uptake or biochemical assays (gel electro-
phoresis and blotting or tra⁄cking assays). For LDL or EGF quan-
titative tra⁄cking assays, cells were transfected for 4^5 h before
starting to internalize the endocytic markers. Samples were examined,
in parallel, by immuno£uorescence for expression of the transfected
construct. Only samples with a transfection e⁄ciency of 70%, or
greater, were utilized in quantitative assays.
2.3. Antibodies
Rabbit polyclonal anti-Rab4 serum was prepared by immunizing
rabbits (Biological Services Unit, UCC) with puri¢ed recombinant
Rab4A protein and a⁄nity-puri¢ed antibody was prepared. The re-
sulting antibody, at a dilution of 1/200 detects as little as 10 ng Rab4p
by Western blotting and did not detect any other Rab protein (Rab1,
Rab3, Rab5 or Rab6) tested under the same conditions. Crude rabbit
polyclonal anti-sera to the early endosomal antigen-1 (EEA1) was a
kind gift of H. Stenmark and was utilized at a dilution of 1/1000 to
detect the endogenous protein. A commercial mouse monoclonal anti-
human TfR antibody (B3/25, Boehringer Mannheim) was utilized to
detect the endogenous TfR by immuno£uorescence.
2.4. Confocal immuno£uorescence microscopy
Cells on 11 mm round glass coverslips were ¢xed with 3% para-
formaldehyde and free aldehyde groups were quenched with 50 mM
NH4Cl. The ¢xed cells were then permeabilized, with 0.05% saponin
or 0.1% Triton X-100 for 5 min and incubated with a rabbit anti-
Rab4 or anti-EEA1 polyclonal antibodies and with a mouse anti-TfR
monoclonal antibody, as primary antibodies. Secondary antibodies
were Texas red (TxR) coupled donkey anti-rabbit and £uorescein
isothiocyanate-coupled (FITC)-conjugated donkey anti-mouse IgG
(Jackson Immunoresearch). Coverslips were mounted in Mowiol
and examined on a Bio-Rad MRC 1024 Zeiss Axioskop confocal
microscope with a 63U/1.40 plan-Apochromat lens. Samples were
excited at wavelengths of 488 and 568 nm and images were processed
using Adobe Photoshop 5.0 software.
2.5. Internalization of £uorescent markers
9 h post-transfection, serum-starved cells grown on glass coverslips,
were incubated for 1 h at 37‡C in the presence of 33 Wg/ml FITC-Tfn
and 3 Wg/ml TxR-coupled EGF (TxR-EGF) from Molecular Probes.
After £uorescent marker uptake, cells were washed brie£y in cold
PBS, ¢xed, quenched and mounted in Mowiol for microscopic exami-
nation, as above.
2.6. GTP overlay blot and immunoblot
HeLa cells were infected and transfected with pGEMmycRab4 con-
structs, as above, and lysed 6 h later in 150 mM NaCl, 50 mM Tris
(pH 8.0), 1% Triton X-100, 0.2% SDS, 0.5% sodium deoxycholate.
Extracts (15 Wg of total cellular protein) were resolved by electropho-
resis on 12% SDS^polyacrylamide gels and transferred to nitrocellu-
lose ¢lters. After transfer, the blot was incubated in binding bu¡er (50
mM sodium phosphate pH 7.5, 10 WM MgCl2, 2 mM DTT, 0.2%
Tween 20, 4 WM ATP) for 30 min at room temperature (RT) followed
by incubation for 1 h at RT in binding bu¡er containing 32P-labelled
GTP at 1 WCi/ml. Blots were then washed in binding bu¡er four times
for 15 min by agitation and exposed to X-ray ¢lm. GTP overlay blots
were stripped of bound GTP by washing the blot in exchange bu¡er
(20 mM Tris^HCl pH 7.5, 1 mM EDTA, 1 mM DTT, 250 mM
ammonium sulfate) followed by incubation for 1 h in (20 mM Tris^
HCl pH 7.5, 5 mM MgCl2, 1 mM EDTA, 50 mM NaCl, 1 mM DTT,
200 WM GDP). Nucleotide stripping was con¢rmed by autoradiogra-
phy and the blot was developed with Rab4 antibodies by blocking and
incubation with the primary antibody (rabbit anti-rab4 serum) at a
1/200 dilution. Filters were washed, incubated with a secondary anti-
rabbit HRP-conjugated antibody for 1 h at RT and the bands were
visualized using the enhanced chemiluminescence system (Pierce).
2.7. Estimation of 125I-LDL internalization, recycling and degradation
Human LDL (1.0196 d6 1.063 g/ml) were obtained by preparative
ultracentrifugation and labelled with 125I as described [28]. The spe-
ci¢c activity of 125I-LDL ranged between 200 and 400 cpm/ng of
protein: more than 98% 125I radioactivity was precipitable by tri-
chloroacetic acid (TCA) and less than 3% was extractable in chloro-
form^methanol. Radioiodinated LDL was always used within 2 weeks
of preparation. Cells were incubated for 24 h in medium comple-
mented with human lipoprotein de¢cient serum (LPDS) before trans-
fection. Cells were then transfected with either the empty vector (con-
trol) or one of the Rab constructs and allowed to internalize 125I-LDL
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that was added to the medium at a concentration of 20 Wg/ml for 5 h
and the amount of 125I-LDL surface bound, internalized and de-
graded was estimated as previously described [28]. To determine the
amount of LDL recycled, cells were incubated for 30 min at 37‡C in
the presence of 125I-LDL at a concentration of 20 Wg/ml. Then the
cells were washed extensively with PBS/0.1% bovine serum albumin
(BSA) on ice and reincubated for 1 h in medium at 37‡C. The medium
was then collected and the TCA precipitable material (125I-LDL re-
cycled) was counted with a Q-counter. To measure kinetics of internal-
ization, cells were incubated at 4‡C in the presence of 125I-LDL
for 2 h, washed extensively with PBS/0.1% BSA on ice and then
incubated in medium at 37‡C for various times. The cells were then
immediately transferred on ice, washed with cold PBS/0.1% BSA and
then the amount of 125I-LDL internalized was determined as described
above.
2.8. Estimation of 125I-EGF recycling and degradation
Human 125I-EGF was purchased from Amersham Biotech. Cells
transfected with either the empty vector (control) or one of the Rab
constructs were incubated with 20 Wg/ml of 125I-EGF in medium lack-
ing serum at 37‡C for 30 min, washed extensively on ice with cold
PBS/0.1% BSA and reincubated in medium without serum at 37‡C for
1 h. The amount of 125I-EGF degraded and recycled was determined
as described [36]. To measure kinetics of internalization, cells were
incubated for di¡erent time points (ranging from 1 to 10 min) in
the presence of 40 Wg/ml 125I-EGF at 37‡C. Cells were then chilled
on ice, washed with cold PBS/0.1% BSA several times, once with
PBS and treated with 3 mg/ml of pronase in serum-free medium
containing 10 mM HEPES, pH 7.3 for 1 h at 0‡C. The cells were
recovered by centrifugation at 3000 rpm for 3 min. The radioactivity
present in pellet (cell-associated) was detected with a Q-counter. Sta-
tistical di¡erences were calculated using a Student t-test for unpaired
data.
2.9. Other assays
Protein concentration was determined by a colorimetric method [37]
with the reagent obtained from either Bio-Rad or BCA (Pierce); re-
crystallized BSA or immunoglobulin G (IgG) were used as standards.
3. Results
3.1. Expression of Rab proteins in transfected HeLa cells
We have used previously generated Rab5 and Rab7 mu-
tated constructs encoding mutant proteins behaving as dom-
inant negative (Rab5S34N, Rab7T22N) or constitutively ac-
tive (Rab5Q79L, Rab7Q67L) [20,28]. Expression of these
constructs in HeLa cells using the vaccinia T7 system resulted
in a strong overexpression (s 15 fold compared to endoge-
nous level, data not shown). We describe here the generation
and characterization of the equivalent Rab4A mutants, dom-
inant negative (S22N) and constitutively activated (Q67L). In
order to verify the biochemical behavior of the mutants, ly-
sates from HeLa cells expressing the Rab4A constructs were
analyzed by SDS^PAGE followed by GTP overlay and im-
munoblotting (Fig. 1). Cells were infected with vaccinia strain
MVA T7 polymerase and transfected 30 min to 1 h later with
pGEMmycRab4WT or pGEMmycRab4S22N or pGEM-
mycRab4Q67L. After transfection, cells were incubated for a
further 6 h to allow expression of the exogenous Rab4 con-
struct. Untreated non-infected, non-transfected (NINT) HeLa
cells were included as a negative control. 15 Wg cell lysate from
each sample was analyzed in the GTP overlay assay and, as
expected, the Rab4S22N mutant was de¢cient in GTP bind-
ing, while wild type and constitutively activated Rab4 e⁄-
ciently bound GTP (Fig. 1A). In order to con¢rm equivalent
sample loading and expression of all Rab4 constructs, the
GTP blot was stripped of nucleotide, stripping was veri¢ed
by autoradiography, and developed as an immunoblot with a
polyclonal anti-Rab4 serum (Fig. 1B). All Rab4 constructs are
expressed at similar levels and vastly in excess of the endog-
enous protein (Fig. 1B). Under the conditions of the experi-
ment endogenous Rab4 is not detectable by immunoblot,
while a strong signal is obtained for all Rab4 constructs.
3.2. E¡ects of Rab4, Rab5 and Rab7 mutant proteins on
LDL kinetics of endocytosis
To compare the e¡ect of overexpression of the di¡erent
Rab4, Rab5 and Rab7WT and mutant proteins on LDL ki-
netics of uptake, we transfected HeLa cells for 4 h with the
di¡erent constructs. We then incubated the cells at 4‡C for
2hrs to allow binding of 125I-LDL and then, after washing,
reincubated the cells for di¡erent times at 37‡C. As shown in
Fig. 2 no e¡ects on the internalization kinetics of 125I-LDL
were detected upon expression of Rab4 and Rab7 WT and
mutant proteins (Fig. 2A,C). In contrast, Rab5WT and
Rab5Q79L expression increased the amount of 125I-LDL in-
ternalized (Fig. 2B), in agreement with previously published
results that Rab5 expression alters the kinetics of endocytosis
of 125I-Tfn [19,20]. Conversely, expression of the Rab5 dom-
inant negative mutant Rab5S34N inhibited the kinetics of
endocytosis (Fig. 2B), again in agreement with previous stud-
ies [19,20]. However, while the kinetics of 125I-Tfn endocytosis
previously reported were dramatically altered by the expres-
sion of Rab5WT and mutant proteins in BHK21 cells [19,20],
the kinetics of endocytosis of 125I-LDL were altered to a lesser
extent by Rab5WT and mutant proteins in this study utilizing
HeLa cells (Fig. 2B) ^ probably a consequence of cell system
experimental di¡erences. Such di¡erences have been previ-
ously reported in EGF internalization kinetics on Rab5 ex-
pression [36].
Fig. 1. GTP overlay assay (A) and immunoblot analysis (B) of
HeLa cells transfected with Rab4WT and mutants. HeLa cells were
infected with MVA T7, transfected with pGEMmycRab4 constructs
and lysed 6 h later. Samples (15 Wg of protein) from untreated
NINT HeLa cells (lane 1); or transfected Rab4WT (lane 2),
Rab4S22N (lane 3), and Rab4Q67L (lane 4), were resolved on a
12% SDS^PAGE and transferred to nitrocellulose ¢lters. The blot
was incubated for 1 h in binding bu¡er containing 32P-labelled GTP
and exposed to X-ray ¢lm (A). The GTP blot was then stripped of
nucleotide and developed using a rabbit anti-Rab4 polyclonal se-
rum. Bands were visualized after incubation with anti-rabbit HRP-
labelled secondary antibody and ECL (B).
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3.3. E¡ects of Rab4, Rab5 and Rab7 mutant proteins on
recycling and degradation
We measured the amount of 125I-Tfn, 125I-LDL and 125I-
EGF recycled in cells expressing the di¡erent Rab constructs.
5 h after transfection, with empty vector or various Rab con-
structs, cells were allowed to internalize 125I-LDL or 125I-EGF
for 30 min at 37‡C, washed on ice extensively with cold PBS/
0.1% BSA and then reincubated for 1 h at 37‡C. The amount
of ligand recycled in the medium was then quanti¢ed. 125I-Tfn
recycling was measured as previously described [17,19]. A
strong inhibition in ligand recycling 30, 60 and 35% for Tfn,
LDL and EGF respectively was evident when the dominant
negative Rab4 mutant was expressed (data not shown). Con-
sistent with this, overexpression of Rab4WT and of the con-
stitutively active mutant Rab4Q67L caused an increase in the
amount of recycled ligands. This increase however was small
(max. 10%). As expected, the recycling of Tfn, LDL or EGF
was not altered by the expression of Rab7WT or mutant
proteins. In the case of Rab5, we observed an increase in
recycling when the dominant negative mutant Rab5S34N
was expressed, again in agreement with previously published
data [36].
We also measured the amount of 125I-LDL or 125I-EGF
degraded in HeLa cells transfected with the di¡erent Rab
WT and mutant proteins. Cells which had been transiently
transfected, with empty vector or various Rab constructs,
for 4^5 h were incubated in the presence of 125I-LDL or
125I-EGF and the amount of both markers degraded was
quanti¢ed as described in Section 2. The results of these ex-
periments are shown in Fig. 3A,B. As expected, when the
Rab7 dominant negative mutant was expressed degradation
was severely impaired (75 and 65% for LDL and EGF, re-
spectively). Degradation was also reduced (50%) in cells ex-
pressing Rab5S34N dominant negative mutant (Fig. 3) as a
consequence of the inhibited internalization and of a dimin-
ished steady state pool of normally functioning EE due to
increased recycling with this mutant (see Section 3.2). Surpris-
ingly, however, when we looked at the e¡ect of Rab4WT and
mutant proteins on degradation we observed that expression
of the dominant negative mutant strongly impaired degrada-
tion, 50 and 30% for LDL and EGF respectively (Fig. 3). In
contrast, expression of Rab4WT or Rab4Q67L did not alter
signi¢cantly degradation of either marker but caused a small
(5^10%) but consistent increase in degradation.
3.4. Rab4WT and mutant expression a¡ects the morphology of
the TfR compartment
As Rab4 a¡ected recycling and degradation of all ligands
we tested whether expression of Rab4WT, Rab4Q67L and
Rab4S22N caused changes in the morphology of the early
endosomal compartment. We therefore monitored the distri-
bution of the TfR as an early endosomal marker in HeLa cells
transfected with the Rab4WT and mutant proteins (Fig. 4.I).
Rab4 constructs were transiently overexpressed for 9 h by
using the T7 RNA polymerase recombinant vaccinia virus
system. The cells were prepared for immuno£uorescence,
and then double-stained with primary and secondary antibod-
ies. Overexpressed Rab4 protein was detected by using an
a⁄nity-puri¢ed rabbit anti-Rab4 polyclonal antibody and
visualized using a TxR-labelled anti-rabbit antibody (red),
while the TfRs were detected with a mouse anti-human TfR
monoclonal antibody and visualized with a FITC-labelled
Fig. 2. Kinetics of 125I-LDL uptake in cells expressing Rab4, Rab5
or Rab7. Cells were infected with the vT7 recombinant vaccinia vi-
rus and transfected with the di¡erent constructs as follows:
A = Rab4; B = Rab5; C = Rab7. For each panel the following key
applies: shaded circle = control cells (cells transfected with empty
vector); unshaded circle = WT Rab; shaded box = dominant positive
Rab mutant (Rab4Q67L, Rab5Q79L or Rab7Q67L); unshaded
box = dominant negative Rab mutant (Rab4S22N, Rab5S34N or
Rab7T22N). After 4 h of transfection, cells were washed extensively
and incubated for 2 h at 4‡C in the presence of 20 Wg/ml of 125I-
LDL. Cells were then washed extensively at 4‡C and reincubated at
37‡C for various times. The amount of 125I-LDL internalized is
plotted as percentage of that prebound. The data with error bars
represent the average of two independent (quadruple sample) experi-
ments.
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anti-mouse antibody (green). In mock-transfected cells (A,B)
the TfR positive compartment showed typical vesicular struc-
tures dispersed throughout the cytoplasm and clusters of TfR
containing vesicles more concentrated in the perinuclear area
(B). In cells overexpressing Rab4WT or mutants (C,E,G) a
di¡use red signal throughout the cell was visualized, indicat-
ing expression of exogenous Rab4. When Rab4WT (C,D) and
Rab4Q67L (E,F) were overexpressed the distribution of TfR-
labelled element was drastically altered, TfR-labelled elements
were found in a tubular network. In contrast, cells overex-
pressing Rab4S22N (G,H) showed a vesicular staining for
Tfn which was mainly concentrated in the perinuclear area.
Some vesicles were also present peripherally in the cytoplasm
but to a lesser extent than in mock-transfected cells. These
results suggest that both the wild type and the active form
of the Rab4 protein (Rab4Q67L) expand the morphology of
the Tfn positive endosomes into a tubular membrane struc-
ture. Conversely, overexpression of the inactive form of Rab4
(Rab4S22N) appears to induce the accumulation of vesicles
into a perinuclear area.
To further investigate the consequences of Rab4 expression
on the early endosomal compartment we transfected HeLa
cells, with the empty vector (Fig. 4.IIA^C), Rab4WT (D^F)
or the Rab4S22N mutant (G^I) and monitored the EEA1
compartment morphology in parallel with TfR. Mock-trans-
fected cells display a typical TfR compartment which co-local-
izes substantially with EEA1, as previously described [38].
Cells transfected with Rab4WT display a tubulated TfR com-
partment (D), with EEA1 localizing to this structure at dis-
tinct, often swollen, domains (varicosities) but not along the
entire structure (E). On the other hand, in cells expressing
Rab4S22N, EEA1 displayed a very ¢ne vesicular pattern con-
centrating in a spherical fashion around the nucleus (H) and
co-localizing substantially with TfR positive vesicles (G).
In order to further characterize the morphology and iden-
tity of the abnormal early endosomal compartment, generated
on Rab4 overexpression, we monitored the localization of
FITC-Tfn in parallel with TxR-EGF in mock-transfected cells
(Fig. 4.IIIA^C) and cells expressing Rab4WT (D^F) or
Rab4S22N (G^I). In control cells, a typical vesicular Tfn pat-
tern was observed (A) while EGF labelled a less peripheral
population of vesicles (B) and displayed partial co-localization
with Tfn vesicles (C). EGF also partially co-localized with
FITC-Tfn when either wild type or the dominant negative
Rab4S22N mutant were expressed. However, the structures
labelled di¡ered. On Rab4WT expression EGF localized pre-
dominantly, but not exclusively, to varicosities of the abnor-
mal Tfn compartment (E). On the other hand, when
Rab4S22N is expressed, the EGF compartment displays a
‘¢ner’ punctate pattern (H) and a higher degree of co-local-
ization with Tfn (compare I and C). To investigate the mor-
phological e¡ects more fully we have done pilot stereological
analysis, using a simple point counting method, on the TxR-
EGF signal in control vs. Rab4GDP expressing sample. The
proportion (of cell volume) containing TxR-EGF in the
Rab4GDP expressing sample is 2.6U greater than that of
the (mock-transfected) control. We have also estimated the
degree of co-localization of FITC-Tfn and Tx-EGF in the
the mock-transfected control as compared with the S22N ex-
pressing sample. The control sample displays 10% co-local-
ization while Rab4S22N displays 50% co-localization, consis-
tent with the view that marker segregation is less e⁄cient
when Rab4GDP is expressed.
4. Discussion
Due to the complexity and dynamic nature of the endocytic
compartment and its tra⁄cking routes, we decided to study
the e¡ects of three small GTPases and mutants thereof in a
single cell type by quantitative methods. In order to cover as
comprehensively as possible all e¡ects of these proteins on
endocytosis and distinguish between direct and secondary ef-
fects, we followed quantitatively intake into the early endo-
somal compartment and exit from this compartment to both
recycling and degradative routes, as well as monitoring the
morphology of the endosomal compartment using early endo-
somal markers. Previous work from di¡erent laboratories has
demonstrated that while Rab5 regulates the initial steps of
transport to EE, Rab4 regulates recycling from this compart-
ment and Rab7 the late steps of endocytosis [17,19,21,27,28].
Fig. 3. E¡ect of Rab4, Rab5 and Rab7, WT and mutant proteins,
on 125I-LDL and 125I-EGF degradation. Cells were infected with the
vT7 recombinant vaccinia virus and transfected with the di¡erent
constructs, or empty vector control, as indicated. After 4^5 h of
transfection, cells were washed extensively and incubated for 30 min
at 37‡C in the presence of 20 Wg/ml of 125I-EGF or 5 h in the pres-
ence of 20 Wg/ml of 125I-LDL. The amount of 125I-LDL (A) and of
125I-EGF (B) degraded was estimated as described in Section 2 and
plotted as percentage of control cells. The data represent the aver-
age of four independent experiments with error bars *P6 0.001;
**P6 0.005; ns, not statistically signi¢cant, compared to control.
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However, these studies were done in di¡erent cell lines utiliz-
ing di¡erent expression systems, di¡erent point mutants and
analyzing di¡erent markers for endocytosis so it is di⁄cult to
directly compare the e¡ect of the three proteins. Therefore, we
considered it important to examine the function of these three
Rab proteins in the same system, utilizing equivalent point
mutations for all three Rabs and following three endocytic
markers. In the quantitative assays, we examined the e¡ect
of Rab4, Rab5 and Rab7 wild type and mutant proteins on
EGF and LDL degradation in HeLa cells. Furthermore, we
examined Tfn, EGF and LDL recycling. We demonstrate that
Rab4 a¡ects degradative tra⁄cking in addition to recycling.
As expected, Rab7 only a¡ected degradation, con¢rming that
it controls late endocytic steps and the expression of the wild
Fig. 4. Morphological alterations of the TfR compartment in HeLa cells overexpressing Rab4WT and mutants. I: HeLa cells were infected
with MVA T7 and transfected for 9 h with empty vector pGEMmyc (A,B), or with plasmids encoding Rab4WT (C,D), Rab4Q67L (E,F), or
Rab4S22N (G,H). The cells were ¢xed, permeabilized and double-stained for confocal microscopy analysis with an a⁄nity-puri¢ed rabbit anti-
Rab4 polyclonal antibody, and with a mouse anti-TfR B3/25 monoclonal antibody. Cells were then visualized using TxR-labelled anti-rabbit
IgG (red), and FITC-labelled anti-mouse IgG (green), as secondary antibodies. II: HeLa cells were infected and transfected with pGEMmyc
(A^C) or with plasmids encoding Rab4WT (D^F) or Rab4S22N (G^I) as above, and double-stained for confocal microscopy with mouse anti-
TfR B3/25 monoclonal antibody and rabbit anti-EEA1 polyclonal antibody, as primary antibodies. Cells were then visualized using TxR-la-
belled anti-rabbit IgG (red), and FITC-labelled anti-mouse IgG (green), as secondary antibodies. A^I: Whole stack projections of the combined
serial sections. White boxes identify selected areas for which a single section is shown (enlarged) on right, aP^iP. III (see next page): HeLa cells
were infected and transfected with pGEMmyc (A^C), Rab4WT (D^F) or Rab4S22N (G^I) as above, and then incubated with FITC-Tfn and
TxR-EGF for 1 h at 37‡C. A^I: Whole stack projections of the combined serial sections. White boxes identify selected areas for which a single
section is shown (enlarged) on right, aP^iP. Scale bar represents 10 Wm.
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type or mutant proteins does not a¡ect internalization or
recycling rates, while Rab5 displays major e¡ects on early
endocytic events.
The Rab4 protein has been found to be associated with an
early endosomal compartment clearly distinct from the late
endosomal compartment, labelled by the Rab7 protein
[16,30,31]. Moreover, Rab4 has been found to play an impor-
tant role in the control of the Tfn recycling pathway [17]. We
Fig. 4 (continued).
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show here that expression of the Rab4S22N dominant nega-
tive mutant (locked in the GDP-bound form) a¡ects strongly
not only recycling (reduced by 30^60%) but also degradation
(reduced by 30^50%). Since the kinetics of internalization
were not a¡ected by expression of any of the Rab4 constructs,
these data indicate that the Rab4 e¡ect is not a consequence
of altered uptake. Only a small increase (up to 10%) was
observed in recycling and degradation in cells overexpressing
Rab4 wild type and the active Rab4Q67L mutant. This minor
e¡ect of Rab4WT on the degradative endosomal pathway is
consistent with a previous report on Rab4 function [17]. The
substantial e¡ects of the dominant negative Rab4S22N mu-
tant, in this study, altering recycling and degradation suggest
that Rab4 is important for sorting from the early endosomal
compartment to both recycling and degradative routes.
The e¡ects of Rab5 are consistent with that previously pub-
lished, where it has been implicated in inward budding from
the plasma membrane, in the fusion of endocytic vesicles with
EE and in the homotypic fusion of EE [18,19,21].
Rab7 function, as expected, appears to be con¢ned to the
late steps of endocytosis since we observe no e¡ects on the
kinetics of uptake or recycling. Therefore, the Rab7 data pre-
sented here are consistent with previously published data im-
plicating Rab7 in the late endosomal/degradative pathway
[26,27,29].
We have also observed by immuno£uorescence that the
overexpression of the Rab4 protein results in morphological
alterations to the TfR compartment. Expression of Rab4 mu-
tants cause opposite morphological changes to this compart-
ment. In cells overexpressing either the wild type or the active
form of Rab4 (Rab4Q67L), the fTfR-labelled elements were
distributed as a tubular network. In contrast, cells overex-
pressing the inactive form of Rab4 protein (Rab4S22N)
showed vesicular staining for the TfR which was mainly con-
centrated in the perinuclear area. Despite the fact that the
Rab4S22N e¡ects on the TfR compartment are not so dra-
matic, we consistently observed this phenotype. Rab4 is be-
lieved to control recycling of TfR from the sorting endosomes
back to the membrane, which can occur directly (fast cycle) or
indirectly via the RC (slow cycle). The immuno£uorescence
results, suggest that both Rab4WT and Rab4Q67L proteins
expand the morphology of the Tfn positive endosomes into a
tubular membrane structure. Since Tfn is present in sorting
endosomes, RC and recycling vesicles it is not possible to
distinguish whether this structure is an abnormal sorting en-
dosome, RC or a recycling vesicle. However, based on the
localization of Rab4 already described [16,30,31,39,40] it is
probable that this compartment is of either sorting endosome
or RC nature. Considering published data on Rab4 localiza-
tion [16,30,31,39,40] and function [17,41] and the e¡ect of the
Rab4S22N mutant on endosomal tra⁄cking to the degrada-
tive pathway (described here), it is likely that the Rab4 e¡ects
are exerted on the sorting endosome rather than the RC. To
better characterize this compartment, we investigated whether
it is decorated by the early endosomal marker EEA1 and if it
contains EGF. We show here that the Tfn positive structure,
generated by Rab4 expression, is positive for both EEA1 and
EGF with both markers decorating a subpopulation of the
Tfn positive swellings/varicosities distributed along the mem-
brane tubules caused by Rab4WT overexpression. The EEA1
signal appears to be perturbed on Rab4WT overexpression
with fewer EEA1 structures labelled than in control cells,
which display a multiple small vesicle pattern. The morpho-
logical e¡ects generated by overexpression of wild type and
Rab4Q67L proteins are likely to be due to an increased pro-
duction of TfR-labelled membrane buds from the sorting en-
dosome resulting in the observed formation of membrane tu-
bules, as Rab4 augments the budding process from this
compartment. Our quantitative results also support this
theory, since a small (max. 10%) increase in recycling and
degradation was observed on overexpression of wild type
and Rab4Q67L proteins. The Rab4S22N protein is in a
GDP-inactive state and, in our model would be expected to
reduce exit from the sorting endosomes. The morphological
and the quantitative data support this theory as we observe
both an accumulation of vesicles containing TfR/FITC-Tfn,
EEA1 and EGF in the perinuclear area, and a strong reduc-
tion in recycling and degradation. We therefore speculate that
the Rab4 protein performs an important role in the normal
functioning of the early sorting endosome, possibly control-
ling the formation of membrane buds destined for transport
to both recycling and degradative acceptor compartments.
The isolation of Rab4 interacting proteins [32,42^45] and
the development of in vitro assays to study Rab4 function
will facilitate future studies for the elucidation of the molec-
ular mechanism of action of this GTPase.
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